Hattori N, Tsuboi Y, Yamamoto A, Sasagawa Y, Nomoto M, ME2125-3 Study Group. Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study. Parkinsonism Relat Disord. 2020 Jun;75:17-23. Epub 2020 May 4 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.